Black Hawk Acquisition Q2: Delisting Notice, Going Concern, Merger Pending
Black Hawk Acquisition Corp. (BKHA) filed its quarterly report, revealing a Nasdaq delisting notice for failing to meet the minimum market value of listed securities requirement. The company's management also issued a going concern warning due to a significant working capital deficit and uncertainty regarding the completion of its business combination. While a Business Combination Agreement with Vesicor Therapeutics is pending, the company experienced substantial share redemptions following an extension vote, significantly reducing its Trust Account balance.
Key Highlights
- Received Nasdaq delisting notice on March 31, 2026, for MVLS below $50M.
- Management issued a "going concern" warning due to cash deficit and business combination uncertainty.
- Net income for Q2 2026 was $88,929, down from $520,542 in Q2 2025.
- Net income for six months ended May 31, 2026, was $228,734, down from $1,178,921 in 2025.
- Total Liabilities increased to $5,166,806 as of May 31, 2026, from $3,897,233.
- Shareholders' Deficit increased to $(5,103,676) from $(3,846,443).
- Business Combination Agreement with Vesicor Therapeutics remains pending.
- 4,775,923 public shares were redeemed for $51.0 million, leaving $22.7 million in Trust Account.
Price Impact
More from BKHA
Black Hawk Acquisition Corp Extends Business Combination Deadline by One Month
Black Hawk Acquisition Extends Business Combination Deadline to Aug 22
BKHA Files 10-K/A, Updates Exhibits with Certifications & Clawback Policy